Tryptamine Therapeutics Limited
TYPTF
$0.015
$0.000.00%
| 12/31/2024 | 09/30/2024 | 02/29/2024 | 11/30/2023 | 08/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -3.52M | -3.56M | -3.92M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 88.30K | 507.60K | 492.90K |
| Change in Net Operating Assets | -- | -- | 88.10K | 365.90K | 732.70K |
| Cash from Operations | -- | -- | -3.34M | -2.68M | -2.69M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -6.00K | -6.00K | -6.00K |
| Cash from Investing | -- | -- | -6.00K | -6.00K | -6.00K |
| Total Debt Issued | -- | -- | 4.84M | 4.81M | 2.15M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 3.55M | 3.54M | 1.58M |
| Foreign Exchange rate Adjustments | -- | -- | -1.70K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 204.90K | 849.60K | -1.11M |
